Clinical Trial Update: Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

This Phase 1 trial update evaluates the pharmacokinetic interaction when simvastatin is coadministered with PEX168 in healthy adult subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PEX168 (PEX168)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED